Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ADALIMUMAB Cause Incorrect dose administered by device? 114 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 114 reports of Incorrect dose administered by device have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.0% of all adverse event reports for ADALIMUMAB.

114
Reports of Incorrect dose administered by device with ADALIMUMAB
0.0%
of all ADALIMUMAB reports
1
Deaths
8
Hospitalizations

How Dangerous Is Incorrect dose administered by device From ADALIMUMAB?

Of the 114 reports, 1 (0.9%) resulted in death, 8 (7.0%) required hospitalization.

Is Incorrect dose administered by device Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 114 reports have been filed with the FAERS database.

What Other Side Effects Does ADALIMUMAB Cause?

Drug ineffective (71,926) Pain (37,514) Arthralgia (35,592) Rheumatoid arthritis (29,817) Fatigue (29,420) Injection site pain (28,679) Headache (19,891) Nausea (19,299) Rash (18,690) Pain in extremity (18,319)

What Other Drugs Cause Incorrect dose administered by device?

EXENATIDE (3,332) EVOLOCUMAB (2,840) SOMATROPIN (2,486) ALBUTEROL (1,236) ETANERCEPT (1,032) SECUKINUMAB (996) ERENUMAB-AOOE (973) BUDESONIDE\FORMOTEROL (753) INSULIN GLARGINE (753) BUDESONIDE\FORMOTEROL\GLYCOPYRROLATE (674)

Which ADALIMUMAB Alternatives Have Lower Incorrect dose administered by device Risk?

ADALIMUMAB vs ADALIMUMAB-AACF ADALIMUMAB vs ADALIMUMAB-AATY ADALIMUMAB vs ADALIMUMAB-ADAZ ADALIMUMAB vs ADALIMUMAB-ADBM ADALIMUMAB vs ADALIMUMAB-AFZB

Related Pages

ADALIMUMAB Full Profile All Incorrect dose administered by device Reports All Drugs Causing Incorrect dose administered by device ADALIMUMAB Demographics